Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Beta Bionics, Inc. (NASDAQ: BBNX)
BBNX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
29.40%
Analyst Rating:
BUY
Analyst Forecast (1yr):
53.80%
BBNX Stock Analysis
BBNX
PE Ratio:
BBNX
PEG Ratio:
Not Available
BBNX
Forward EPS Growth (12 month):
0.00%
BBNX
PS Ratio:
5
BBNX
PSG Ratio:
0.1
BBNX
Forward Revenue Growth (12 month):
35.00%
BBNX Articles
No data was found